<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000758198">
  <TermName>Myleran</TermName>
  <TermPronunciation>(MY-leh-ran)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that contains the active ingredient busulfan and is used to treat chronic myelogenous leukemia.  Myleran damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000760862" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Myleran&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000760861" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Myleran&quot;" language="es" id="_4"/>
  <SpanishTermName>Myleran</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene el ingrediente activo busulfano y se usa para el tratamiento de la leucemia mielógena crónica. Myleran daña el ADN de las células y es posible que destruya células cancerosas. Es un tipo de alquilante.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2014-02-24</DateFirstPublished>
</GlossaryTerm>
